These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 31128154)
21. In vitro and in vivo experimental models employed in the discovery and development of antiepileptic drugs for pharmacoresistant epilepsy. Campos G; Fortuna A; Falcão A; Alves G Epilepsy Res; 2018 Oct; 146():63-86. PubMed ID: 30086482 [TBL] [Abstract][Full Text] [Related]
22. New strategies for the identification of drugs to prevent the development or progression of epilepsy. Schmidt D; Rogawski MA Epilepsy Res; 2002 Jun; 50(1-2):71-8. PubMed ID: 12151119 [TBL] [Abstract][Full Text] [Related]
23. Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians. Krauss GL; Brandt J; Campbell M; Plate C; Summerfield M Neurology; 1996 Jun; 46(6):1534-9. PubMed ID: 8649543 [TBL] [Abstract][Full Text] [Related]
24. Challenges in the clinical development of new antiepileptic drugs. Franco V; French JA; Perucca E Pharmacol Res; 2016 Jan; 103():95-104. PubMed ID: 26611249 [TBL] [Abstract][Full Text] [Related]
25. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Canevini MP; De Sarro G; Galimberti CA; Gatti G; Licchetta L; Malerba A; Muscas G; La Neve A; Striano P; Perucca E; Epilepsia; 2010 May; 51(5):797-804. PubMed ID: 20545754 [TBL] [Abstract][Full Text] [Related]
26. Recent advances in adjunctive therapy for epilepsy: focus on sodium channel blockers as third-generation antiepileptic drugs. Vohora D; Saraogi P; Yazdani MA; Bhowmik M; Khanam R; Pillai KK Drugs Today (Barc); 2010 Apr; 46(4):265-77. PubMed ID: 20502724 [TBL] [Abstract][Full Text] [Related]
27. Antiepileptic drug therapy. Podell M Clin Tech Small Anim Pract; 1998 Aug; 13(3):185-92. PubMed ID: 9775509 [TBL] [Abstract][Full Text] [Related]
28. New avenues for anti-epileptic drug discovery and development. Löscher W; Klitgaard H; Twyman RE; Schmidt D Nat Rev Drug Discov; 2013 Oct; 12(10):757-76. PubMed ID: 24052047 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic strategies in the choice of antiepileptic drugs. de Borchgrave V; Delvaux V; de Tourchaninoff M; Dubru JM; Ghariani S; Grisar T; Legros B; Ossemann M; Sadzot B; Tugendhaft P; Van Bogaert P; van Rijckevorsel K; Acta Neurol Belg; 2002 Mar; 102(1):6-10. PubMed ID: 12094563 [TBL] [Abstract][Full Text] [Related]
30. Effect of in utero exposure to antiepileptic drugs on cognitive function in children. Vashishth K; Singh R; Medhi B Pharmacology; 2013; 92(5-6):315-8. PubMed ID: 24335199 [TBL] [Abstract][Full Text] [Related]
32. Epileptogenesis, ictogenesis and the design of future antiepileptic drugs. Weaver DF Can J Neurol Sci; 2003 Feb; 30(1):4-7. PubMed ID: 12619776 [TBL] [Abstract][Full Text] [Related]
33. Pharmacological considerations in the use of stiripentol for the treatment of epilepsy. Verrotti A; Prezioso G; Stagi S; Paolino MC; Parisi P Expert Opin Drug Metab Toxicol; 2016; 12(3):345-52. PubMed ID: 26890312 [TBL] [Abstract][Full Text] [Related]
34. Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options. Löscher W; Potschka H; Sisodiya SM; Vezzani A Pharmacol Rev; 2020 Jul; 72(3):606-638. PubMed ID: 32540959 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of p38 mitogen-activated protein kinase signaling reduces multidrug transporter activity and anti-epileptic drug resistance in refractory epileptic rats. Shao Y; Wang C; Hong Z; Chen Y J Neurochem; 2016 Mar; 136(5):1096-105. PubMed ID: 26677173 [TBL] [Abstract][Full Text] [Related]
36. The use of monotherapy in patients with epilepsy: an appraisal of the new antiepileptic drugs. Kanner AM; Balabanov AJ Curr Neurol Neurosci Rep; 2005 Jul; 5(4):322-8. PubMed ID: 15987617 [TBL] [Abstract][Full Text] [Related]
37. New drugs for pediatric epilepsy. Chu-Shore CJ; Thiele EA Semin Pediatr Neurol; 2010 Dec; 17(4):214-23. PubMed ID: 21183127 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and adverse effects of established and new antiepileptic drugs. Mattson RH Epilepsia; 1995; 36 Suppl 2():S13-26. PubMed ID: 8784211 [TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic considerations for anti-epileptic drugs in children. Verrotti A; Iapadre G; Di Donato G; Di Francesco L; Zagaroli L; Matricardi S; Belcastro V; Iezzi ML Expert Opin Drug Metab Toxicol; 2019 Mar; 15(3):199-211. PubMed ID: 30689454 [TBL] [Abstract][Full Text] [Related]
40. Neurotoxins from invertebrates as anticonvulsants: from basic research to therapeutic application. Mortari MR; Cunha AO; Ferreira LB; dos Santos WF Pharmacol Ther; 2007 May; 114(2):171-83. PubMed ID: 17399793 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]